First-episode psychosis induced by pregabalin withdrawal: a case report
Open Access
- 9 April 2018
- journal article
- case report
- Published by AVES YAYINCILIK A.Ş. in Psychiatry and Clinical Psychopharmacology
- Vol. 28 (4) , 461-463
Abstract
Pregabalin is a novel isomer of gamma-aminobutyric acid that functions as a major inhibitory neurotransmitter in the brain. It is used daily in medical practice for treating neuropathic pain, fibromyalgia, generalized anxiety disorder, and partial seizures. Due to its anti-glutamatergic effects, it poses a potential addiction risk. For example, an abrupt discontinuation of this substance may cause patients to exhibit physical withdrawal symptoms, such as insomnia, nausea, headache, and diarrhoea. However, there is no information in the literature that addresses whether the rapid discontinuation of pregabalin can cause psychosis to occur. Here we presented a 20-year-old patient with his first episode of psychosis that was likely attributable to his withdrawal from a high dosage pregabalin. He lacked physical signs of withdrawal; however, a psychiatric examination was conducted. It was determined that the patient was experiencing paranoid ideation, auditory hallucinations, and mutism. Furthermore, he had engaged in self-mutilative actions and had attempted suicide. Due to the short time frame between the rapid discontinuation of a relatively large dose of pregabalin and the onset of the patient’s first episode of psychosis, it is likely that the psychotic episode was triggered by the cessation of the medication. This is the first known case of psychosis that was caused by the rapid withdrawal of pregabalin to be discussed in the literature. The results of this clinical case may guide clinicians to recognize the symptoms of acute pregabalin withdrawal.Keywords
This publication has 10 references indexed in Scilit:
- Temazepam withdrawal induced psychosisAsian Journal of Psychiatry, 2011
- Pregabalin abuse: a case report / Pregabalin kötüye kullanımı: Bir olgu sunumuKlinik Psikofarmakoloji Bülteni / Bulletin of Clinical Psychopharmacology, 2011
- Probing GABA Receptor Function in Schizophrenia with IomazenilNeuropsychopharmacology, 2010
- A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and GabapentinClinical Pharmacokinetics, 2010
- A signal for an abuse liability for pregabalin—results from the Swedish spontaneous adverse drug reaction reporting systemEuropean Journal of Clinical Pharmacology, 2010
- Pregabalin og misbrukspotensialTidsskrift for Den norske legeforening, 2009
- Efficacy of Pregabalin in the Treatment of Generalized Anxiety DisorderJournal of Clinical Psychopharmacology, 2005
- Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophreniaBiological Psychiatry, 1999
- Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia [published erratum appears in Am J Psychiatry 1997 May;154(5):722]American Journal of Psychiatry, 1997
- Benzodiazepine withdrawal: an unfinished story.BMJ, 1984